MORGANELLA
Compiled by: Zenisha Acharya
Rashmi Shrestha
Central Department of
Microbiology
Tribhuvan University
Kirtipur, Kathamndu
•
Morganella morganii
is named after Morgan (1906) who isolated it from the feces of infants with
diarrhea.
•
Rauss (1936) suggested it was closely
related to Proteus because, it produces indole, degraded urea, and exhibited spreading
growth on media with reduced agar concentrations at 20-28˚C .
•
The observation by Henriksen and Closs
(1938) that both Proteus and Morgan’s bacillus degraded phenylalanine to
phenyl pyruvic acid gave additional support to the suggestion and for many
years the organism was known as Proteus morganii.
•
The proposal of Kauffmann (1956) that it
should be placed in a separate genus, Morganella did not at first
receive general acceptance, but the evidence in its favor is now overwhelming:
the G+C content of the DNA of Morganella is considerably higher than
that of Proteus.
•
DNA-DNA hybridization studies show less
than 20 percent genetic homology between the two genera and other members of
the Proteae (Brenner et al. 1978); there are differences in the properties of
enzymes common to Morganella and other members of the tribe.
Classification
•
Domain: Bacteria
•
Phylum: Proteobacteria
•
Class:
Gammaproteobacteria
•
Order:
Enterobacteriales
•
Family: Enterobacteriaceae
•
Tribe:
Proteae
•
Genus:
Morganella
•
Species: M. morganii
•
The genus has one species M. morganii
with two subspecies based largely on the ability of strains to form lysine or
ornithine decarboxylase or both or neither.
Ø Morganella
morganii subspecies morganii
trehalose non-fermenter
Biogroups: A,B,C ,D
Ø Morganella
morganii subspecies sibonii
trehalose fermenter
Biogroups : E,F,G
Habitat
•
M. morganii is
commonly found in the environment and in the intestinal tracts of humans,
mammals, and reptiles as normal flora.
•
Although M. morganii has
a wide distribution, it is considered an uncommon cause of community-acquired
infection and it is most often encountered in postoperative and
other nosocomial infections such as urinary tract infections.
Epidemiology
•
Morganella species
are infrequent causes of disease in healthy individuals. M. morganii was
originally thought to be a cause of summer diarrhea. The organism has been
isolated along with Proteus mirabilis more
frequently in patients with diarrhea than in healthy controls .
•
M. morganii
is found in the environment and in the intestinal tracts of humans, mammals,
and reptiles as part of the normal flora.Therefore, most M. morganii bacteremia
cases were opportunistic community-acquired infections.
Morphology
•
These are straight, non-spore forming ,
non-capsulated gram negative rods measuring
0.6-0.7 µm in diameter and 1.0-1.7 µm in length.
•
They are motile by means of peritrichous
flagella, but some strains do not form flagella above 30˚C.
•
After 48 hrs on 1% agar media at 22˚C
growth may spread to form a surface film.
•
Swarming does not occur.
•
G +C content of the DNA is 50 mol%.
Cultural
characteristics
• They
are facultative anaerobe require both niacin and pantothenic acid for growth.
• They
grow readily on most culture media as convex colonies 2-3 mm in diameter after
overnight incubation at 37˚C.
Ø Nutrient
broth
• Cultures
have an unpleasant smell
Ø Blood agar

Ø Selective
media: Mac Conkey
• They
form colorless colonies on Mac Conkey, eosin-methylene blue,
xylose-lysine-deoxycholate, and Salmonella-Shigella agars.
Biochemical
characteristics
•
Oxidase:
negative
•
Catalase: positive
•
Urease: positive
•
Indole: positive
•
Methyl Red: positive
•
Voges Proskauer: positive
•
Citrate: negative
•
H 2 S: negative
•
Phenylalanine deaminase: positive
•
Ornithine-decarboxylase:
positive
•
Ferment glucose and mannose only
•
Gelatin not liquefied
Virulence factors
Ø Hemolysin:
•
It is calcium-dependent hemolysin
•
It is serologically and functionally
identical to E. coli hemolysin
HlyA
Ø MR/K
hemagglutinin:
•
that enhances adherence to urinary
catheters
Ø Urease:
•
High affinity for urea and the potential
to cause alkalinization of urine and stone formation, this rarely happens in
vivo in man
•
Bifunctional urease which is activated
at acid pH .
•
The
role of the urease to promote colonization of the intestinal tract by
protecting the organism against the acidity of the stomach
Virulence factors of
M. morganii
• Category
Genes
•
Fimbrial adhesins Three MR/P(mannose-resistant/Proteus-like
fimbria) operons, 13 mrpJ paralogous, one fimbrial chaperone, two
•
UCA(uroepithelial cell adhesin) operons,
one PMF(P. mirabilis fimbria) operon, and two other operons; six putative type
IV pili
•
genes hofCB and ppdABCD; two putative
trimeric auto transporter secretion genes MM2011 and MM2042
•
Motility/flagellum-related cheA, cheW,
cheD, tap, cheR, cheB, cheY, cheZ, umoABCD, rssBA, rcsBCD
•
T3SS Type III secretion system needle
complex (20 genes), and effectors, ipaCBD operon
•
Iron acquisition system hmuSTUV, afuABC,
feoAB, ireA, btuCD, btuB, and yfeDCBA, 18 other related genes (fecR, ABC
transporters, TonB-dep. receptors)
•
IgA protease zapABCD
•
Toxin hmpBA, tccB, tccA, tcdB2, xptA1,
xptC1, tcdA4, tcaC, tccB3, and tcaC
•
rtxA, xaxAB, intimin/invasion, HlyD
toxin secretion, toxin transporter
•
Two-component systems 19 potential TCSs
were identified. qseBC, yedWV, BarA/UhpA, phoP/phoQ.
•
LPS and the cell capsule wzzE, rffC,
rffA, wzxE, pagP, arnT, msbA, lpxK, kdsB, kdsC, fepE/wzz, htrB/waaM, rfaD/waaD,
rfaF/waaF, rfaC/waaC, wabH, wabG,
•
waaQ/rfaQ, waaA, waaE, coaD, rfaL,
hldE/rfaE, lpxD, lpxA, lpxB, msbB, kdsA, rfaB, lpxH, pgi, galU, lpxC, gale,
wecA, rffE, wecC, rffG, rffH,
•
rffT, wzyE, rffMrcsB, rcsC, rcsD and
rcsF.
•
Ureases ureABCEFGD
Clinical manifestation
Ø Diarhhoea:
They are normal faecal
flora that often causes infection in patients whose normal flora have been
disturbed by antibiotic therapy.
Ø UTI:
Urinary tract infection
is the most common clinical infection site. Most often these occur in
elderly patients in nursing homes with long-term indwelling catheters. Morganella is
the fifth leading cause of UTIs in nursing home patients.
•
skin and soft tissue infections
•
intra-abdominal infections
•
biliary infection, liver abscess and
peritonitis
•
bacteremia
•
diabetic foot infections
•
septic arthritis
•
meningitis
•
otitis media
•
gastroenteritis
•
neonatal sepsis
•
Pericarditis
•
Chorioaminonitis
•
Histamine food poisoning
Laboratory diagnosis
Ø Specimen:
According to site of infection
•
Faeces
•
Urine
•
Wound swab
•
ear swab
•
blood
Direct microscopy:
Ø These
are straight
Ø gram
negative rods
Ø measuring 0.6-0.7 µm in diameter and 1.0-1.7 µm in
length
Culture:
• They
grow readily on most culture media as convex colonies 2-3 mm in diameter after
overnight incubation at 37˚C.
Ø Nutrient
broth:
• cultures
have an unpleasant smell
Ø Blood
agar
Approximately 30
percent of strains are hemolytic on blood agar through the production of a
calcium dependent hemolysin
They form colorless
colonies on Mac Conkey, eosin-methylene blue, xylose-lysine-deoxycholate, and
Salmonella-Shigella agars
Ø Biochemical
tests:
Ø Oxidase: negative
Ø Catalase: positive
Ø Urease: positive
Ø Indole: positive
Ø Methyl
Red: positive
Ø Voges
Proskauer: positive
Ø Citrate: negative
Ø H
2 S: negative
Ø Phenylalanine
deaminase: positive
Ø Ornithine-decarboxylase: positive
Ø Ferment
glucose and mannose only
Ø Gelatin not liquefied
Tests |
Proteus |
Morganella |
Providencia |
Swarming |
+ve |
-ve |
-ve |
Urea hydrolysis |
+ve |
+ve |
v |
Citrate utilization test |
v |
-ve |
+ve |
Gelatin liquefication |
+ve |
-ve |
-ve |
Ornithine decarboxylase test |
v |
+ve |
Others
Ø PCR
Ø Serotyping
Ø Biotyping
Ø Phenotyping
Treatment
•
M. morganii
strains are usually sensitive to quinolones, such as nalidixic acid and
ciprofloxacin, to aminoglycosides such as gentamicin and tobramycin, to
trimethoprim, cotrimoxazole, chloramphenicol, and aztreonam, and the
carbapenems imipenem and meropenem.
Prevention
•
Hand washing practices
•
Use of contact isolation for infected or
colonized patients.
• If
there are multiple different clones of ESBL producing organisms in a hospital,
changes in antibiotic use policy in the hospital may have a role in decreasing
the number of these organisms
References
Holt, J.G., et al.
1994. Bergey's Manual of Determinative Bacteriology , 9th
edition Williams & Wilkins, Baltimore, MD.
3. W.W.C Topley, Topley
& Wilson's principles of bacteriology, virology and immunity, London
4. www.hardlink.com /Bacterial Database
Search,
6. Mackie, T. J., Collee, J. G.McCartney, J. E.
(1996). Mackie & McCartney practical medical microbiology. New
York ; Churchill Livingstone
Comments
Post a Comment